Cytotoxic Potential, Metabolic Profiling, and Liposomes of Coscinoderma sp. Crude Extract Supported by in silico Analysis

References

• Henseler C, Nordström MC, Törnroos A, et al. Coastal habitats and their importance for the diversity of benthic communities: a species-and trait-based approach. Estuar Coast Shelf Sci. 2019;226:106272. doi:10.1016/j.ecss.2019.106272
   Google Scholar
• Farag MA, Fekry M, Al-Hammady M, et al. Cytotoxic effects of Sarcophyton sp. soft corals—Is there a correlation to their NMR fingerprints? Mar Drugs. 2017;15:211. doi:10.3390/md15070211
   PubMed Web of Science ®Google Scholar
• Alves A, Sousa E, Kijjoa A, Pinto M. Marine-derived compounds with potential use as cosmeceuticals and nutricosmetics. Molecules. 2020;25:2536. doi:10.3390/molecules25112536
   PubMedGoogle Scholar
• Avila C, Angulo-Preckler C. Bioactive compounds from marine heterobranchs. Mar Drugs. 2020;18:657. doi:10.3390/md18120657
   PubMedGoogle Scholar
• Musa A, Al-muaikel N, Abdel-Bakky M. Phytochemical and pharmacological evaluations of ethanolic extract of. Bassia Eriophora, Bassia Eriophora Der Pharma Chem. 2016;8:169–178.
   Google Scholar
• Mioso R, Marante F, Bezerra R, et al. Cytotoxic compounds derived from marine sponges. A review (2010–2012). Molecules. 2017;22:208. doi:10.3390/molecules22020208
   PubMedGoogle Scholar
• Meisner D, Mezei M. Liposome ocular delivery systems. Adv Drug Delivery Rev. 1995;16:75–93. doi:10.1016/0169-409X(95)00016-Z
   Web of Science ®Google Scholar
• Refaat H, Naguib YW, Elsayed M, Sarhan HA, Alaaeldin E. Modified spraying technique and response surface methodology for the preparation and optimization of propolis liposomes of enhanced anti-proliferative activity against human melanoma cell line A375. Pharmaceutics. 2019;11:558. doi:10.3390/pharmaceutics11110558
   PubMed Web of Science ®Google Scholar
• Mostafa M, Alaaeldin E, Aly UF, Sarhan HA. Optimization and characterization of thymoquinone-loaded liposomes with enhanced topical anti-inflammatory activity. AAPS PharmSciTech. 2018;19:3490–3500. doi:10.1208/s12249-018-1166-1
   PubMed Web of Science ®Google Scholar
• Refaat H, Mady FM, Sarhan HA, Rateb HS, Alaaeldin E. Optimization and evaluation of propolis liposomes as a promising therapeutic approach for COVID-19. I J pharmaceutics. 2020;120028.
   PubMedGoogle Scholar
• Alaaeldin E, Abu Lila AS, Ando H, et al. Co-administration of liposomal l-OHP and PEGylated TS shRNA-lipoplex: a novel approach to enhance anti-tumor efficacy and reduce the immunogenic response to RNAi molecules. J Controlled Release. 2017;255:210–217. doi:10.1016/j.jconrel.2017.04.040
   PubMedGoogle Scholar
• Singh AV, Hosseinidoust Z, Park B-W, Yasa O, Sitti M. Microemulsion-based soft bacteria-driven microswimmers for active cargo delivery. ACS Nano. 2017;11:9759–9769. doi:10.1021/acsnano.7b02082
   PubMed Web of Science ®Google Scholar
• Rajabi M, Adeyeye M, Mousa SA. Peptide-conjugated nanoparticles as targeted anti-angiogenesis therapeutic and diagnostic in cancer. Cur Med Chem. 2019;26:5664–5683. doi:10.2174/0929867326666190620100800
   PubMedGoogle Scholar
• Fan Y, Marioli M, Zhang K. Analytical characterization of liposomes and other lipid nanoparticles for drug delivery. J Pharm Biomed Anal. 2020;113642.
   PubMedGoogle Scholar
• Juszkiewicz K, Sikorski AF, Czogalla A. Building Blocks to Design Liposomal Delivery Systems. Int J Mol Sci. 2020;21:9559. doi:10.3390/ijms21249559
   PubMedGoogle Scholar
• Alaaeldin E, Abu Lila AS, Moriyoshi N, et al. The co-delivery of oxaliplatin abrogates the immunogenic response to PEGylated siRNA-lipoplex. Pharm Res. 2013;30:2344–2354. doi:10.1007/s11095-013-1078-4
   PubMed Web of Science ®Google Scholar
• Charcosset C, Juban A, Valour J-P, Urbaniak S, Fessi H. Preparation of liposomes at large scale using the ethanol injection method: effect of scale-up and injection devices. Chem Eng Res Des. 2015;94:508–515. doi:10.1016/j.cherd.2014.09.008
   Web of Science ®Google Scholar
• Jaafar-Maalej C, Diab R, Andrieu V, Elaissari A, Fessi H. Ethanol injection method for hydrophilic and lipophilic drug-loaded liposome preparation. J Liposome Res. 2010;20:228–243. doi:10.3109/08982100903347923
   PubMed Web of Science ®Google Scholar
• Abdelmohsen UR, Cheng C, Viegelmann C, et al. Dereplication strategies for targeted isolation of new antitrypanosomal actinosporins A and B from a marine sponge associated-Actinokineospora sp. EG49 Mar Drugs. 2014;12:1220–1244. doi:10.3390/md12031220
   PubMed Web of Science ®Google Scholar
• Shamikh YI, El Shamy AA, Gaber Y, et al. Actinomycetes from the Red Sea sponge Coscinoderma mathewsi: isolation, diversity, and potential for bioactive compounds discovery. Microorganisms. 2020;8:783. doi:10.3390/microorganisms8050783
   PubMedGoogle Scholar
• Alzarea SI, Elmaidomy AH, Saber H, et al. Potential anticancer lipoxygenase inhibitors from the red sea-derived brown algae sargassum cinereum: an in-silico-supported In-Vitro Study. Antibiotics. 2021;10:416. doi:10.3390/antibiotics10040416
   Google Scholar
• Lagunin A, Stepanchikova A, Filimonov D, Poroikov V. PASS: prediction of activity spectra for biologically active substances. Bioinformatics. 2000;16:747–748. doi:10.1093/bioinformatics/16.8.747
   PubMed Web of Science ®Google Scholar
• Seeliger D, de Groot BL. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J Comput -Aided Mol Des. 2010;24:417–422. doi:10.1007/s10822-010-9352-6
   PubMed Web of Science ®Google Scholar
• Hyosu M, Kimura J. Two new spongian diterpenes from Coscinoderma mathewsi. J Nat Prod. 2000;63:422–423. doi:10.1021/np990464e
   PubMedGoogle Scholar
• Bokesch HR, Pannell LK, McKee TC, Boyd MR. Coscinamides A, B and C, three new bis indole alkaloids from the marine sponge Coscinoderma sp. Tetrahedron Lett. 2000;41:6305–6308. doi:10.1016/S0040-4039(00)01062-5
   Web of Science ®Google Scholar
• Gonzalez, M A. Scalarane sesterterpenoids. Curr Bioact Compd. 2010;6:178–206. doi:10.2174/157340710793237362
   Google Scholar
• Jeong H, Latif A, Kong C-S, et al. Isolation and characterization of antiplasmodial constituents from the marine sponge Coscinoderma sp. Zeitschrift für Naturforschung C. 2019;74:313–318. doi:10.1515/znc-2019-0039
   PubMedGoogle Scholar
• Kimura J, Ishizuka E, Nakao Y, et al. Isolation of 1-methylherbipoline salts of halisulfate-1 and of suvanine as serine protease inhibitors from a marine sponge, coscinoderma m athewsi. J Nat Prod. 1998;61:248–250. doi:10.1021/np970376z
   PubMedGoogle Scholar
• Lee J-W, Lee H-S, Shin J, et al. Suvanine analogs from a Coscinoderma sp. marine sponge and their cytotoxicities against human cancer cell lines. Arch Pharmacal Res. 2015;38:1005–1010. doi:10.1007/s12272-014-0479-1
   PubMedGoogle Scholar
• Singh AV, Ansari MHD, Rosenkranz D, et al. Artificial intelligence and machine learning in computational nanotoxicology: unlocking and empowering nanomedicine. Adv Health Mat. 2020;9:1901862. doi:10.1002/adhm.201901862
   Web of Science ®Google Scholar
• Singh AV, Rosenkranz D, Ansari MHD, et al. Artificial intelligence and machine learning empower advanced biomedical material design to toxicity prediction. Adv. Intellig. Sys. 2020;2:2000084. doi:10.1002/aisy.202000084
   Google Scholar
• Xu C, Lu P, Gamal El-Din TM, et al. Computational design of transmembrane pores. Nature. 2020;585:129–134. doi:10.1038/s41586-020-2646-5
   PubMedGoogle Scholar
• Frankson R, Yu Z-H, Bai Y, et al. Therapeutic targeting of oncogenic tyrosine phosphatases. Cancer Res. 2017;77:5701–5705. doi:10.1158/0008-5472.CAN-17-1510
   PubMed Web of Science ®Google Scholar
• Pinch BJ. Identification of a potent and selective covalent Pin1 inhibitor. Nat Chem Biol. 2020;1–9.
   Google Scholar
• Sarver P, Acker M, Bagdanoff JT, et al. 6-Amino-3-methylpyrimidinones as potent, selective, and orally efficacious SHP2 inhibitors. J Med Chem. 2019;62:1793–1802. doi:10.1021/acs.jmedchem.8b01726
   PubMedGoogle Scholar
• Zhang D, Iyer LM, He F, Aravind L. Discovery of novel DENN proteins: implications for the evolution of eukaryotic intracellular membrane structures and human disease. Front Genet. 2012;3:283.
   PubMedGoogle Scholar
• Sreenivasulu R, Reddy KT, Sujitha P, Kumar CG, Raju RR. Synthesis, antiproliferative and apoptosis induction potential activities of novel bis (indolyl) hydrazide-hydrazone derivatives. Bioorg Med Chem. 2019;27:1043–1055. doi:10.1016/j.bmc.2019.02.002
   PubMed Web of Science ®Google Scholar
• Shaker DS, Shaker MA, Hanafy MS. Cellular uptake, cytotoxicity and in-vivo evaluation of Tamoxifen citrate loaded niosomes. I J Pharmaceutics. 2015;493:285–294. doi:10.1016/j.ijpharm.2015.07.041
   PubMed Web of Science ®Google Scholar
• Paolino D, Cosco D, Muzzalupo R, et al. Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. I J Pharmaceutics. 2008;353:233–242. doi:10.1016/j.ijpharm.2007.11.037
   PubMed Web of Science ®Google Scholar
• Alvi IA. Comparative study of transfersomes, liposomes, and niosomes for topical delivery of 5-fluorouracil to skin cancer cells: preparation, characterization, in-vitro release, and cytotoxicity analysis. Anticancer Drugs. 2011;22:774–782. doi:10.1097/CAD.0b013e328346c7d6
   PubMed Web of Science ®Google Scholar
• Salatin S, Maleki Dizaj S, Yari Khosroushahi A. Effect of the surface modification, size, and shape on cellular uptake of nanoparticles. Cell Biol Int. 2015;39:881–890. doi:10.1002/cbin.10459
   PubMed Web of Science ®Google Scholar
• Singh AV, et al. Machine-learning-based approach to decode the influence of nanomaterial properties on their interaction with cells. ACS Appl Mater Interfaces. 2020.
   Google Scholar
• Singh AV, Jahnke T, Wang S, et al. Anisotropic gold nanostructures: optimization via in silico modeling for hyperthermia. ACS Appl. Nano Mater. 2018;1:6205–6216. doi:10.1021/acsanm.8b01406
   Google Scholar
• Hajizadeh MR, Maleki H, Barani M, et al. In vitro cytotoxicity assay of D-limonene niosomes: an efficient nano-carrier for enhancing solubility of plant-extracted agents. Res Pharm Sci. 2019;14:448. doi:10.4103/1735-5362.268206
   PubMed Web of Science ®Google Scholar
• Tran MA, Watts RJ, Robertson GP. Use of liposomes as drug delivery vehicles for treatment of melanoma. Pigm Cell Melanoma Res. 2009;22:388–399. doi:10.1111/j.1755-148X.2009.00581.x
   PubMed Web of Science ®Google Scholar
• Xu L, Wempe MF, Anchordoquy TJ. The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro. Ther Delivery. 2011;2:451–460. doi:10.4155/tde.11.13
   PubMedGoogle Scholar